As reported on Science Daily, a breast cancer vaccine tested more than 20 years ago is drawing renewed scientific interest after researchers discovered that every
Editor’s Note: Patient Worthy is honored to share part 2 in an ongoing 10-part series, written and shared with us by Elena Genik. Before the
Cancer immunotherapy represents one of modern medicine’s greatest achievements, yet it’s also one of its most frustrating paradoxes: a treatment that works miracles for some
As reported on BioSpace, Moderna has entered a commercialization partnership with Italy‑based Recordati to support the development of mRNA‑3927, an investigational mRNA therapy for propionic
Osteosarcoma is a diagnosis no family should ever have to face. It is the most common primary bone cancer in children and adolescents, yet treatment
A groundbreaking genetic study published in The Journal of Clinical Endocrinology & Metabolism and reported by ScienceDaily.com has revealed that obesity and high blood pressure
Twenty years is a long time to believe a cancer chapter has closed. For two decades after my radical prostatectomy, I lived with the quiet
Editor’s Note: Patient Worthy is honored to share part 1 in an ongoing 10-part series, written and shared with us by Elena Genik. When Everything
A growing body of research shows that sleep quality, dietary sodium, and hypertension are more closely linked than once believed — and two major healthcare
Vera Therapeutics announced a major milestone in drug development on January 7, 2026, when the U.S. Food and Drug Administration granted Priority Review to the
As reported by the European Pharmacy Review, a combination approach using Johnson & Johnson’s small‑molecule therapy Caplyta (lumateperone) alongside standard antidepressants continues to show promising
A newly published Phase 1/2 study in The New England Journal of Medicine, and reported on by the Manila Times, highlights promising early results for tividenofusp
A New Approach to a Persistent Problem Celcuity has reached a critical inflection point in its pursuit of a novel breast cancer treatment. The FDA’s
As reported on Healio, glucagon-like peptide-1 (GLP-1)–based therapies are rapidly reshaping the landscape of diabetes and chronic kidney disease (CKD) management. Originally developed for glycemic
Immunoglobulin A nephropathy (IgAN) remains one of the most common primary glomerular diseases worldwide, yet effective treatments are limited. A new study, recently published in
If you got past the title without rolling your eyes or getting angry (I understand if you did either or both as you will see
Breaking the Cycle of Prescription Dependency The opioid epidemic that has devastated American communities for decades may finally have a novel challenger. According to Bezinga.com,
As reported by Clinical Trials Arena, Axsome Therapeutics has begun dosing patients in its FORWARD Phase III clinical trial, a pivotal study designed to evaluate
Understanding the symptoms and causes of cutaneous squamous cell carcinoma (SCC) is more than just medical knowledge — it’s a vital step toward early detection and better outcomes. SCC is one of the most common forms of skin cancer, and while it’s highly treatable when caught early, it can become serious if it goes unnoticed. That’s why paying attention to changes in your skin and knowing what factors increase risk can make a life-changing difference.
Awareness empowers people to act sooner, ask questions, and seek care when something doesn’t seem right. It also encourages better sun protection, healthier habits, and stronger conversations with loved ones who may be at risk. The more we understand what to look for and what contributes to SCC, the faster we can prevent small concerns from becoming major ones. Knowledge truly saves lives. If you have a story to share, click the link below!
bit.ly/4dV7gru
#SquamousCellCarcinoma #SkinHealthMatters #PatientWorthy #ShareYourStory
Meet Tessa, who was diagnosed with Acromegaly in 2015. In honor of Rare Disease Month, Tessa shares her experiences living with a rare disease that isn’t visible to others. Her message is one of resilience, self-acceptance, and community. “You are RARE. You MATTER. You are a WARRIOR.” Please read Tessa's full story here: bit.ly/4arl3WI
Share your rare disease journey with us here: bit.ly/4dV7gru
# Acromegaly #RareButNotAlone #RareDiseaseWeek #PatientWorthy
During Rare Disease Month, Patient Worthy is honored to share a story from Mary, who has been diagnosed with Granulomatosis with polyangiitis (GPA), formerly known as Wegener's disease.
"My name is Mary, and I am 71 years young. I am a wife, mother, and grandma. After working as an LVN/Nurse for 43 years, I retired. I love family time, cooking, gardening, and stained glass. My autoimmune disease started probably long before being diagnosed on April 4, 2022. I was in the hospital again, this time for kidney failure, and my kidney biopsy came back positive for Wegener's disease (GPA)–vasculitis. It has involved my kidneys, heart, lungs, eyes, and hearing. After two years of treatments and Peritoneal Dialysis (PD), I was blessed with healing. I healed enough to be able to stop dialysis. Many symptoms of the disease continue, so I continue to do oral treatments for immune therapy as recommended for me. Empower yourselves. Ask questions, be strong, and fight for your cure in your autoimmune disease."
#RareDiseaseMonth #RareDisease #RareButNotAlone #WeCareAboutRare #ShareYourStripes #ShareYourStory #PatientWorthy #Wegenersdisease #vasculitis #GPA
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
